MitoMYcin 40 mg
RxNorm 1740897
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1740897 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: mitoMYcin 40 mg.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
TMSYPrescribable
Tall Man Lettering Synonym (TMSY):
MitoMYcin 40 mg
(Atom ID: 7745017)
SCDCPrescribable
Semantic Clinical Drug Component (SCDC):
Mitomycin 40 mg
(Atom ID: 12276770)
Patient Education
Mitomycin
Mitomycin is used in combination with other medications to treat cancer of the stomach or pancreas that has spread to other parts of the body and has not improved or worsened after treatment with other medications, surgery, or radiation therapy. Mitomycin is a type of antibiotic that is only used in cancer chemotherapy. It slows or stops the growth of cancer cells in your body.
[Learn More]
Mitomycin Pyelocalyceal
Mitomycin pyelocalyceal is used to treat a certain type of urothelial cancer (cancer of the lining of the bladder and other parts of the urinary tract) in adults. Mitomycin is in a class of medications called anthracenediones (anticancer antibiotics). Mitomycin pyelocalyceal treats cancer by stopping the growth and spread of certain cells.
[Learn More]
* Please review the disclaimer below.